Who owns CHEMOMAB THERAPEUTICS LTD?
- Ticker: CMMB
- CUSIP Number: 16385c104
Tip: Access positions for across all investors
Analyze quarterly positions in Chemomab Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Chemomab Therapeutics stock
Who bought or sold CHEMOMAB THERAPEUTICS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 1.7M | $2.7M | -22% | Sep 2024 |
|
| Yelin Lapidot Holdings Management | 810k | $1.3M | 100% | Sep 2024 |
|
| Ikarian Capital | 213k | $335k | 0% | Sep 2024 |
|
| Kestra Private Wealth Services | 31k | $49k | 0% | Sep 2024 |
|
| Rhumbline Advisers | 28k | $43k | 39% | Sep 2024 |
|
| Two Sigma Investments | 24k | $22k | -39% | Jun 2024 |
|
| Two Sigma Advisers | 18k | $17k | -52% | Jun 2024 |
|
| Hrt Financial | 14k | $21k | 100% | Sep 2024 |
|
| Morgan Stanley | 7.2k | $6.6k | 157% | Jun 2024 |
|
| Jpmorgan Chase & Co | 1.1k | $1.7k | 110000% | Sep 2024 |
|
| Moser Wealth Advisors | 500.00 | $785.000000 | 0% | Sep 2024 |
|
| Qube Research & Technologies | 44.00 | $40.000400 | 0% | Jun 2024 |
|
Who sold out of Chemomab Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2024 | 62k | $57k |
| Two Sigma Securities | Mar 2024 | 26k | $20k |
| XTX Topco | Jun 2024 | 15k | $14k |
| Geode Capital Management | Jun 2024 | 12k | $11k |